CPT 532U — Rare diseases (constitutional disease/hereditary disorders), rapid whole genome and mitochondrial DNA sequencing for single-nucleotide variants, insertions/deletions, copy number variations, peripheral blood, buffy coat, saliva, buccal or tissue sample, r (33 hospitals, — samples)
CPT 533T — Continuous Recording Of Movement Disorder Symptoms For 8-10 Days With Set-Up, Patient Training, Configuration Of Monitor, Upload Of Data , Analysis And Initial Report Configuration, Download Of Review, Interpretation And Report (7 hospitals, — samples)
CPT 533U — Drug metabolism (adverse drug reactions and drug response), genotyping of 16 genes (ie, ABCG2, CYP2B6, CYP2C9, CYP2C19, CYP2C, CYP2D6, CYP3A5, CYP4F2, DPYD, G6PD, GGCX, NUDT15, SLCO1B1, TPMT, UGT1A1, VKORC1), reported as metabolizer status and transporter (33 hospitals, — samples)
CPT 53451 — TPRNL BALO CNTNC DEV BI (552 hospitals, — samples)
CPT 53452 — 53452 Tprnl Balo Cntnc Dev Uni W/ Image Tech (551 hospitals, — samples)
CPT 53453 — TPRNL BALO CNTNC DEV RMVL EA (552 hospitals, — samples)
CPT 534T — Continuous Recording Of Movement Disorder Symptoms For 8-10 Days With Set-Up, Patient Training, Configuration Of Monitor (7 hospitals, — samples)
CPT 534U — Oncology (prostate), microRNA, single-nucleotide polymorphisms (SNPs) analysis by RT-PCR of 32 variants, using buccal swab, algorithm reported as a risk score (33 hospitals, — samples)
CPT 535T — Continuous Recording Of Movement Disorder Symptoms For 8-10 Days With Data Upload, Analysis And Initial Report Configuration (7 hospitals, — samples)
CPT 535U — Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), by liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma or serum, quantitative (33 hospitals, — samples)
CPT 536U — Red blood cell antigen (fetal RhD), PCR analysis of exon 4 of RHD gene and housekeeping control gene GAPDH from whole blood in pregnant individuals at 10+ weeks gestation known to be RhD negative, reported as fetal RhD status (33 hospitals, — samples)
CPT 537U — Oncology (colorectal cancer), analysis of cell-free DNA for epigenomic patterns, next-generation sequencing, >2500 differentially methylated regions (DMRs), plasma, algorithm reported as positive or negative (33 hospitals, — samples)
CPT 53866 — Catheterization with removal of temporary device for ischemic remodeling (ie, pressure necrosis) of bladder neck and prostate (588 hospitals, — samples)
CPT 538U — Oncology (solid tumor), next-generation targeted sequencing analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis of 600 genes, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, and copy number (33 hospitals, — samples)
CPT 539U — Oncology (solid tumor), cell-free circulating tumor DNA (ctDNA), 152 genes, next-generation sequencing, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, copy number alterations, and microsatellite instability, using (33 hospitals, — samples)
CPT 53U — Fish Analysis Of 4 Genes In Prostate Needle Biopsy Specimen (7 hospitals, — samples)
CPT 540U — Transplantation medicine, quantification of donor-derived cell-free DNA using next-generation sequencing analysis of plasma, reported as percentage of donor-derived cell-free DNA to determine probability of rejection (33 hospitals, — samples)
CPT 541T — MYOCARDIAL IMAGING MCG (81 hospitals, — samples)
CPT 541U — Cardiovascular disease (HDL reverse cholesterol transport), cholesterol efflux capacity, LC-MS/MS, quantitative measurement of 5 distinct HDL-bound apolipoproteins (apolipoproteins A1, C1, C2, C3, and C4), serum, algorithm reported as prediction of corona (33 hospitals, — samples)
CPT 542U — Nephrology (renal transplant), urine, nuclear magnetic resonance (NMR) spectroscopy measurement of 84 urinary metabolites, combined with patient data, quantification of BK virus (human polyomavirus 1) using real-time PCR and serum creatinine, algorithm re (33 hospitals, — samples)
CPT 543U — Oncology (solid tumor), next-generation sequencing of DNA from formalin-fixed paraffin-embedded (FFPE) tissue of 517 genes, interrogation for single- nucleotide variants, multi-nucleotide variants, insertions and deletions from DNA, fusions in 24 genes an (33 hospitals, — samples)
CPT 544U — Nephrology (transplant monitoring), 48 variants by digital PCR, using cell-free DNA from plasma, donor-derived cell-free DNA, percentage reported as risk for rejection (15 hospitals, — samples)
CPT 545U — Acetylcholine receptor (AChR), antibody identification by immunofluorescence, using live cells, reported as positive or negative (33 hospitals, — samples)
CPT 546U — Low-density lipoprotein receptor-related protein 4 (LRP4), antibody identification by immunofluorescence, using live cells, reported as positive or negative (33 hospitals, — samples)
CPT 548U — Glial fibrillary acidic protein (GFAP), chemiluminescent enzyme immunoassay, using plasma (33 hospitals, — samples)
CPT 549U — Oncology (urothelial), DNA, quantitative methylated real-time PCR of TRNA-Cys, SIM2, and NKX1-1, using urine, diagnostic algorithm reported as a probability index for bladder cancer and/or upper tract urothelial carcinoma (UTUC) (33 hospitals, — samples)
CPT 552U — Reproductive medicine (preimplantation genetic assessment), analysis for known genetic disorders from trophectoderm biopsy, linkage analysis of disease-causing locus, and when possible, targeted mutation analysis for known familial variant, reported as lo (33 hospitals, — samples)
CPT 553U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements, aneuploidy, and a mitochondrial DNA score, results reported as normal/ba (33 hospitals, — samples)
CPT 554U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from trophectoderm biopsy for aneuploidy, ploidy, a mitochondrial DNA score, and embryo quality control, results reported as normal (33 hospitals, — samples)